1.	VEG113971: An Open-Label Study of the Effects of Ketoconazole or Esomeprazole on Pazopanib PK Phase: Phase IV Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 113971, NCT01205230
2.	Antiandrogen Withdrawal in Treating Patients With Hormone-Refractory Prostate Cancer Phase: Phase III Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: any age Sponsor: NCI, Other Protocol IDs: CDR0000064708, U10CA031946, CLB-9583, CALGB-9583, NCT00002760
3.	Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer Phase: Phase III Type: Treatment Status: Completed Age: no age specified Sponsor: NCI, Other Protocol IDs: DM95-231, P30CA016672, MDA-DM-95231, NCI-G96-1044, CDR0000065105, NCT00002855
4.	Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer Phase: Phase III Type: Treatment Status: Closed Age: Any age Sponsor: NCI, Other Protocol IDs: ID00-156, U10CA045809, P30CA016672, MDA-ID-00156, NCI-3410, CDR0000068897, 3410, NCT00024167
5.	Phase III Randomized Study of Androgen Blockade With Concurrent Chemotherapy Versus Delayed Chemotherapy in Patients With High-Risk Hormone-Naive Prostate Cancer Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: RTOG-P-0014, RTOG-DEV-1028, ECOG-RTOG-P-0014, CALGB-RTOG-P-0014, SWOG-RTOG-P-0014, NCT00030654
6.	Phase III Management and Prophylaxis of Fever and Infection with Antimicrobial Treatment in Cancer Patients (Study III) Phase: Phase III Type: Supportive care Status: Closed Age: no age specified Sponsor: Protocol IDs: NCI-81-C-189, NCI-POB-8103
7.	Phase III MOX/AMK vs MOX/PIP for Suspected Infection in Febrile, Granulocytopenic Cancer Patients, with Amphotericin-B or Ketoconazole for Failures Phase: Phase III Type: Supportive care Status: Closed Age: no age specified Sponsor: Protocol IDs: UMCC-8107
8.	Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancer Phase: Phase III Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000069088, E1899, SWOG-E1899, CALGB-E1899, ECOG-E1899, NCT00027859
9.	Phase I/II Study of IL-1A/MITO with Ketoconazole for Metastatic Colorectal and Prostate Carcinomas (Summary Last Modified 08/95) Phase: Phase II, Phase I Type: Supportive care, Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: CRB-9202, NCI-T94-0090N, T94-0090
10.	Ixabepilone and Ketoconazole in Treating Patients With Advanced Solid Tumors Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000393439, AECM-03099, AECM-CA163402, AECM-NMC-03-10-277C, NCT00096317
11.	Phase II Randomized Study of Ketoconazole vs DOX/Ketoconazole in Hormone-Refractory Prostate Carcinoma (Summary Last Modified 04/95) Phase: Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: NCI Protocol IDs: MDA-DM-95010, NCI-T95-0012D, T95-0012
12.	Phase II Randomized Study of Tretinoin Modulation by Ketoconazole or Disulfiram in Hormone-Refractory Prostate Cancer (Summary Last Modified 01/99) Phase: Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: NCI Protocol IDs: PCI-9437, NCI-T94-0173D, T94-0173
13.	Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate Cancer Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: DM97-022, P30CA016672, MDA-DM-97022, NCI-T97-0023, CDR0000065783, T97-0023, NCT00003084
14.	Phase II Randomized Study of High-Dose Ketoconazole With or Without Alendronate Sodium in Patients With Androgen-Independent Metastastic Adenocarinoma of the Prostate Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-99-C-0052, NCT00019695
15.	Hydrocortisone Plus Aminoglutethimide or Ketoconazole in Treating Patients With Localized Stage IV Prostate Cancer Phase: Phase II Type: Treatment Status: Completed Age: Not specified Sponsor: NCI, Other Protocol IDs: CDR0000068244, MCC-12219, MCC-IRB-5722, NCI-G00-1863, NCT00006371
16.	Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate Cancer Phase: Phase II Type: Supportive care, Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000068536, MSKCC-00113, NCI-G01-1927, NCT00014352
17.	Phase II Pilot Study of the Effects of High-Dose Ketoconazole in the Management of Stage D Prostatic Carcinoma Phase: Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: NCOG-P-4P831, NCOG-P-4P-83-1
18.	Phase II Study of Endocrine Therapy with Ketoconazole in Patients with Metastatic Prostate Adenocarcinoma Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: WCCC-CO-8586, NCI-T86-0145D, T86-0145
19.	Phase II Management of Fever and Infection in Cancer Patients --- Fever Study IV (Summary Last Modified 06/97) Phase: Phase II Type: Supportive care Status: Completed Age: any age Sponsor: NCI Protocol IDs: NCI-85-C-212C, NCI-T86-0036N, T86-0036
20.	Phase II Study of Taxol and G-CSF in Patients with Refractory or Recurrent Ovarian Cancer (Summary Last Modified 04/93) Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-90-C-191G, NCI-T90-0219N, T90-0219
21.	Phase II Study of VP-16 plus Chemotherapy Resistance Modulators in the Treatment of VP-16-Resistant Malignancies Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Protocol IDs: CAN-OTT-9008, NCI-V91-0084
22.	Phase II Randomized Study of Bromocriptine or Ketoconazole in Patients with Androgen-Independent Metastatic Prostate Cancer Resistant to Prior Hormonal Therapy Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Protocol IDs: NCI-91-C-223
23.	Phase II Randomized Study of Paclitaxel, Etoposide, and Estramustine Versus Ketoconazole, Doxorubicin, Vinblastine, and Estramustine Versus Cyclophosphamide, Vincristine, and Dexamethasone Versus Carboplatin, Estramustine, and Paclitaxel in Patients With Progressive Androgen-Independent Prostate Cancer Phase: Phase II Type: Treatment Status: Closed Age: Any age Sponsor: NCI Protocol IDs: MDA-DM-98223
24.	Phase II Randomized Study of Neoadjuvant Androgen Ablation With or Without Chemotherapy in Patients With Locally Advanced Prostate Cancer Undergoing Radical Prostatectomy Phase: Phase II Type: Treatment Status: Closed Age: Not specified Sponsor: NCI Protocol IDs: MDA-ID-99061
25.	Docetaxel Combined With Ketoconazole in Treatment of Breast Cancer Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: BR01/07/05, NCT00212095